Workshop Overview
Pharmacovigilance is the science relating to the detection, assessment, understanding and prevention of the adverse effects of medicines. When Hippocrates in 500BC stated ’PRIMUM NON NOCERE’ or ’First, do no harm’ he could not have envisaged the central role that pharmacovigilance would have in assisting physicians meet this cornerstone of medicine.
This workshop will provide delegates with an understanding of the importance of the role of pharmacovigilance in the drug development process and life cycle of a therapeutic good.
The workshop analyses the role of pharmacovigilance throughout the product lifecycle. It explores the legislative and corporate governance requirements that are essential to the function. Key processes for the management of adverse events are reviewed, in clinical trials and the post approval environment. Attendees will learn how application of the science behind pharmacovigilance in the safety management of a product can minimise risks and meet our primary goal of preventing harm to the patient.
Speaker Information
Sreeja Sudharkaran | Teaching Associate, Faculty of Pharmacy | Monash University
Vivien Shen | Pharmacovigilance Therapy Area Specialist | AbbVie
14:00, Monday, 19 Oct 2026 + 2 more
14:00, Tuesday, 20 Oct 2026
14:00, Wednesday, 21 Oct 2026
